JOHN SIMARD - 17 Mar 2025 Form 4 Insider Report for XBiotech Inc. (XBIT)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: John Simard
Issuer symbol: XBIT
Transactions as of: 17 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 19 Mar 2025, 15:03:42 UTC
Previous filing: 04 Feb 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SIMARD JOHN	Chief Executive Officer, Director, 10%+ Owner	5217 WINNEBAGO LANE, AUSTIN	John Simard	19 Mar 2025	0001639078

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XBIT	Stock Option	Award	$0	+1,026,228	+118%	$0.000000	1,896,609	17 Mar 2025	Common Stock	1,026,228	$3.52	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 17, 2025 (the Grant Date) John Simard was granted nonstatutory stock options under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock at an exercise price equal to the closing price of the Company's common stock, as reported by the Nasdaq Stock Market, on the Grant Date. The options vested immediately on the Grant Date.